{
  "abstract": "Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by chronic neuroinflammation, metabolic dysfunction, and impaired proteostasis. Emerging evidence suggests that the gut microbiome influences brain function through the gut–brain axis; however, the mechanisms by which this communication affects AD pathology remain poorly understood. In this study, we used humanized Drosophila AD models expressing human AD-related transgenes in glial cells to investigate how glial AD pathology influences the gut microbiome and how microbiome depletion affects behavior and disease progression. Our findings revealed significant alterations in the abundance of several gut microbial taxa, including Lactobacillus, Acetobacter, Enterococcus, Enterobacter, Pseudomonas, Leuconostoc, Providencia, and Gluconobacter, suggesting a potential interaction between the gut microbiome and AD progression. To further define the role of the gut microbiome in AD progression, we treated Drosophila with antibiotics to achieve substantial microbiome depletion (SMD) and evaluated the resulting behavioral, physiological, and molecular changes. Compared with conventional controls, flies with SMD exhibited enhanced inflammatory signaling and cell death, impaired autophagy, lipid dysregulation, and increased accumulation of amyloid β-42 (aβ42) and phospho-tau (pTau), with the extent of these changes varying among the different humanized AD models. These molecular alterations further exacerbated sleepcircadian disruption, altered locomotor performance, and worsened learning and memory deficits. Furthermore, we demonstrated a link between enhanced neuroinflammation and the accumulation of aβ42, pTau, and amyloid precursor protein (APP) proteins. Collectively, our findings demonstrate that gut microbiome depletion aggravates glial-mediated AD pathology through the coordinated disruption of inflammatory, metabolic, and proteostatic pathways, ultimately leading to behavioral dysfunction. These results identify the gut microbiome as a critical regulator of glial homeostasis and provide new insights into its contribution to the progression of neurodegenerative disorders.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA",
    "UAB Nathan Shock Center, Birmingham, AL, USA"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Kishore Madamanchi"
    },
    {
      "affs": [
        0
      ],
      "name": "Srinath Gurrala"
    },
    {
      "affs": [
        0
      ],
      "name": "John Watson"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Girish Melkani",
      "orcid": "0000-0003-0353-4633"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/efvsft28c89f4.bib",
  "cited_by": 0,
  "doi": "10.1080/19490976.2026.2753247",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757599/",
  "id": "efvsft28c89f4",
  "issns": [
    "1949-0976",
    "1949-0984"
  ],
  "landing_url": "https://doi.org/10.1080/19490976.2026.2753247",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "2804|Alzheimer's disease research and treatments"
    ]
  ],
  "openalex": "W7162108178",
  "pdf_url": "https://www.tandfonline.com/doi/pdf/10.1080/19490976.2026.2753247?needAccess=true",
  "pmcid": "PMC13757599",
  "pmid": "42999037",
  "published": "2026-11-08",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/efvsft28c89f4.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:12Z",
      "native_id": "PMC13757599",
      "source": "pmc",
      "url": "https://doi.org/10.1080/19490976.2026.2753247"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:2804|Alzheimer's disease research and treatments",
      "subfield": "neuroscience"
    }
  ],
  "title": "Gut microbiome depletion aggravates glial-mediated Alzheimer’s disease pathology through inflammatory, metabolic, and proteostatic dysregulation",
  "title_text": "Gut microbiome depletion aggravates glial-mediated Alzheimer’s disease pathology through inflammatory, metabolic, and proteostatic dysregulation",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:12Z",
  "url": "https://research.draconitic.com/paper/efvsft28c89f4",
  "venue": "Gut Microbes",
  "versions": []
}